1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Structural heart defects

Tafamidis for treating transthyretin amyloidosis with cardiomyopathy

Technology appraisal guidance [TA696] Published: 12 May 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Appraisal consultation committee papers PDF 7.51 MB 12 May 2021  
  • Final appraisal determination committee papers PDF 2.34 MB 12 May 2021